Martin Tami Tillotson 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Award
Common Stock
2024-02-23+1,250→ 87,418 total - Tax Payment
Common Stock
2024-02-23$29.06/sh−485$14,094→ 86,933 total - Disposition to Issuer
Restricted Stock Unit
2024-02-23−1,250→ 3,750 total→ Common Stock (1,250 underlying)
Footnotes (3)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024.